Related Experiment Video
Updated: Feb 3, 2026
Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV
Published on: September 14, 2010
Novel MXD4-NUTM1 fusion transcript identified in primary ovarian undifferentiated small round cell sarcoma
Ryo Tamura1, Hirofumi Nakaoka2, Kosuke Yoshihara1
1Department of Obstetrics and Gynecology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Abstract:
Primary ovarian sarcomas are extremely rare tumors, and their genomic and transcriptomic alterations remain to be elucidated. We performed whole exome sequencing of primary tumor and matched normal blood samples derived from one patient with ovarian undifferentiated small round cell sarcoma. We identified 8 nonsynonymous somatic mutations, and all mutations were missense or nonsense changes. Next, we performed RNA sequencing of the tumor sample and identified two in-frame fusion transcripts: MXD4-NUTM1 and ARL6-POT1. Most NUTM1 exons were retained in the MXD4-NUTM1 fusion transcript, and we confirmed an increase in NUTM1 mRNA and protein expression in tumor tissue. Further genomic and transcriptomic analyses might lead to the development of new therapeutic strategies based on the molecular characteristics of ovarian undifferentiated small round cell sarcoma.
Insights
This study investigated the rare ovarian undifferentiated small round cell sarcoma, identifying key genetic alterations. Findings include specific mutations and fusion transcripts, offering potential for targeted ovarian cancer therapies.
Area of Science:
- Oncology
- Genomics
- Transcriptomics
Background:
- Primary ovarian sarcomas are rare and poorly understood.
- Genomic and transcriptomic landscape of ovarian undifferentiated small round cell sarcoma requires elucidation.
Observation:
- Whole exome sequencing and RNA sequencing were performed on a primary tumor and matched normal blood sample.
- Eight nonsynonymous somatic mutations were identified, all missense or nonsense.
- Two in-frame fusion transcripts, MXD4-NUTM1 and ARL6-POT1, were discovered.
Findings:
- The MXD4-NUTM1 fusion transcript retained most NUTM1 exons.
- Increased NUTM1 mRNA and protein expression were confirmed in tumor tissue.
- Specific genomic and transcriptomic alterations in this rare sarcoma subtype were characterized.
Implications:
- These molecular findings provide a foundation for understanding ovarian undifferentiated small round cell sarcoma.
- Further research may lead to novel therapeutic strategies targeting identified molecular characteristics.
- This study contributes to the molecular characterization of rare gynecologic cancers.
Related Concept Videos
02:45Nuclear Fusion
A helium nucleus has a mass that is 0.7% less than that of four hydrogen nuclei; this lost mass is converted into energy during the fusion. This reaction produces about...
02:16Transcription Factors
01:10Transcription
Transcription is the process of synthesizing RNA from a DNA sequence by RNA polymerase. It is the first step in producing a protein from a gene sequence. Additionally, many other proteins and regulatory sequences are involved in the proper synthesis of messenger RNA (mRNA). Regulation of transcription is responsible for the differentiation of all the different types of cells and often for the proper cellular response to environmental signals.
Transcription Can Produce Different Kinds...
02:42Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
02:23Master Transcription Regulators
02:35Transcription Elongation Factors
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...